FIRST TRUST ADVISORS LP

Position in MNKD — Mannkind Corp

CIK 1125816 Wheaton, IL

Position in MNKD

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$2,129,672

-$1,199,672 QoQ

Shares Held

869,254

+48.0% QoQ

Ownership

0.281%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FIRST TRUST ADVISORS LP holds $2,375,392,616 across 80 Biotechnology names. MNKD ranks #62 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	346,855	$267,994,047
2	INCY	Incyte Corp	1,500,792	$141,254,543
3	VRTX	Vertex Pharmaceuticals Inc / Ma	306,461	$136,847,094
4	ALNY	Alnylam Pharmaceuticals, Inc.	382,701	$126,624,279
5	MRNA	Moderna, Inc.	2,392,693	$121,548,804
6	EXEL	Exelixis, Inc.	2,534,992	$108,725,806
7	AXSM	Axsome Therapeutics, Inc.	577,479	$97,605,500
8	HALO	Halozyme Therapeutics, Inc.	1,482,340	$95,803,634

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,129,672	869,254	+48.0%	Shares	Sole	2026-05-13
2025-12-31	$3,329,344	587,186	+77.9%	Shares	Sole	2026-02-13
2025-06-30	$1,234,162	329,990	-56.9%	Shares	Sole	2025-08-13
2025-03-31	$3,850,575	765,522	-1.5%	Shares	Sole	2025-05-14
2024-12-31	$4,998,212	777,327	+668.7%	Shares	Sole	2025-02-13
2024-03-31	$458,091	101,124	-84.9%	Shares	Sole	2024-05-13
2023-12-31	$2,436,954	669,493	+213.7%	Shares	Sole	2024-02-13
2023-09-30	$881,457	213,428	-20.8%	Shares	Sole	2023-11-13
2023-06-30	$1,096,620	269,440	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.